Iovance Biotherapeutics, Inc.
Clinical trials sponsored by Iovance Biotherapeutics, Inc., explained in plain language.
-
Fighting cancer with a Patient's own supercharged immune cells
Disease control CompletedThis study tested a personalized cell therapy called LN-144 for people with advanced melanoma that had spread and did not respond to prior treatments. Doctors took immune cells from a patient's own tumor, grew large numbers of them in a lab, and then infused them back into the pa…
Phase: PHASE2 • Sponsor: Iovance Biotherapeutics, Inc. • Aim: Disease control
Last updated Apr 01, 2026 14:41 UTC
-
Early trial tests re-engineered immune cells against tough blood cancers
Disease control CompletedThis early-stage study tested a new cell therapy called IOV-2001 for patients with chronic lymphocytic leukemia or small lymphocytic lymphoma that had returned or stopped responding to standard drugs. The main goals were to find a safe dose and see if the treatment could shrink t…
Phase: PHASE1 • Sponsor: Iovance Biotherapeutics, Inc. • Aim: Disease control
Last updated Mar 23, 2026 15:17 UTC